KV Pharmaceutical Co. defrauded shareholders with false and misleading statements about its generic drugs, a class action claims in St. Louis Federal Court.
Endo Pharmaceutical Holdings is buying Indevus Pharmaceuticals in an unfair transaction for $4.50 per share, shareholders say in Delaware Chancery Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026